Ghost Tree Capital, LLC Global Blood Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $1.54 Million - $2.14 Million	-60,000 Closed	0 $0
Q4 2021 Feb 16, 2022	BUY	$24.9 - $40.26 $1.49 Million - $2.42 Million	60,000 New	60,000 $1.76 Million
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $1.39 Million - $2.91 Million	-33,400 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $1.53 Million - $2.73 Million	33,400 New	33,400 $2.66 Million
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $13.6 Million - $17.4 Million	-300,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $8 Million - $10.7 Million	200,000 Added 200.0%	300,000 $15.9 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $2.78 Million - $4.11 Million	88,000 Added 733.33%	100,000 $4.11 Million
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $8.74 Million - $11.8 Million	-230,000 Reduced 95.04%	12,000 $456,000
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $9.37 Million - $12.1 Million	242,000 New	242,000 $10.9 Million
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $12.9 Million - $21.4 Million	-325,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $2.23 Million - $3.43 Million	75,000 Added 30.0%	325,000 $12.8 Million
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $6.28 Million - $7.76 Million	250,000	250,000 $7.76 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.